An open, single center, clinical investigation to evaluate the efficacy and safety of a non-hormonal vaginal moisturizer for the symptomatic treatment of vulvovaginal atrophy in postmenopausal woman
Objective To evaluate the efficacy and safety of a non-hormonal vaginal moisturizer in alleviating the clinical symptoms of vulvovaginal atrophy (VVA).Methods This was an observational, single center, open label study in which the investigational product was applied to postmenopausal women (n = 36)...
Saved in:
| Main Authors: | Manuel Sánchez-Prieto, Nicolás Mendoza, Peter Chedraui, Félix Lugo-Salcedo, Aida Serra-Ribas, Sonia Aladrén-Pérez, Javier Bustos-Santafé, Rafael Sánchez-Borrego |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gynecological Endocrinology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09513590.2025.2500480 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Feasibility Study Investigating a Topical Preparation as Novel Adjunct Treatment for the Symptomatic Management of Vulvovaginal Skin Conditions
by: Philip Hall
Published: (2024-04-01) -
Vulvovaginal atrophy: current methods of diagnosis and treatment
by: L. F. Zainetdinova, et al.
Published: (2024-04-01) -
Vulvovaginal atrophy: modern approaches to diagnostics and management
by: V. H. Siusiuka, et al.
Published: (2024-01-01) -
Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
by: A. D. Makatsariya, et al.
Published: (2019-09-01) -
Signs and symptoms of vulvovaginal atrophy (VVA) in clinical practice – the possible involvement of thyroid autoimmunity in genitourinary syndrome of menopause (GSM)
by: Laura Cucinella, et al.
Published: (2025-12-01)